Company: XERI
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001477932-25-008494
Chunk: 45

Company: XERIANT, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Part I, Item 1
Chunk 45
---
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 F-5Table of Contents

XERIANT, INC. 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

UNAUDITED

  For the three months ended   September 30,   2025  2024        Cash Flows from Operating Activities      Net Income (Loss) $2,226,072  $(372,222)Adjustments to reconcile net loss to net        cash used by operating activities:            Depreciation and amortization  465   378     Stock issued for services  59,500   217,512     Gain on extinguishment of debt  (2,743,546)  -     Amortization of debt discount  44,031   16,802     Amortization of right of use asset  1,031   13,566 Changes in operating assets and liabilities:                  Prepaids   2,279   (8,861)          Accounts payable and accrued liabilities  85,900   (197,218)          Accrued liability, related party  23,000   (7,999)          Taxes payable  124,585   -           Lease liabilities  (1,031)  (15,053)Net cash used in operating activities  (177,714)  (353,095)         Cash Flows from Investing Activities        Net cash from financing activities  -   -          Cash Flows from Financing Activities        Proceeds from convertible notes payable  185,000   - Net cash provided by financing activities  185,000   -          Net change in cash  7,286   (353,095)         Cash at beginning of period  44,850   653,117          Cash at end of period $52,136  $300,022          Supplemental Cash Flow Information        Cash paid for interest $-  $- Cash paid for income taxes $-  $-          Non-cash investing and financing activities:        Conversion of convertible notes payable and accrued interest $335,501  $269,501 Warrants issued with convertible notes payable $